Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study-Reference-Cited by-同舟云学术

Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

Published:2022-03 Issue: Volume:Volume 17 Page:517-533
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Koopman Maud^ORCID,Franssen Frits ME^ORCID,Gaffron Swetlana,Watz Henrik,Troosters Thierry,Garcia-Aymerich Judith^ORCID,Paggiaro Pierluigi,Molins Eduard,Moya Miguel,van Burk Lindy,Maier Dieter,Garcia Gil Esther,Wouters Emiel FM,Vanfleteren Lowie EGW^ORCID,Spruit Martijn A^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference39 articles.

1. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

2. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD

3. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial

4. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial

5. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact and timing of pulmonary rehabilitation in patients undergoing bronchoscopic lung volume reduction with endobronchial valves: A multicentre randomized controlled trial in patients with severe emphysema;Respirology;2024-05-08

2. Network meta-analysis of the efficacy and safety of monoclonal antibodies and traditional conventional dichotomous agents for chronic obstructive pulmonary disease;Frontiers in Medicine;2024-02-13

3. Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study;International Journal of Chronic Obstructive Pulmonary Disease;2023-06

4. Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview;Expert Review of Clinical Pharmacology;2022-11-02